428 related articles for article (PubMed ID: 24115369)
1. Dapagliflozin treatment for type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials.
Zhang M; Zhang L; Wu B; Song H; An Z; Li S
Diabetes Metab Res Rev; 2014 Mar; 30(3):204-21. PubMed ID: 24115369
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of dapagliflozin as monotherapy in patients with type 2 diabetes mellitus: A meta-analysis of randomized controlled trials.
Feng M; Lv H; Xu X; Wang J; Lyu W; Fu S
Medicine (Baltimore); 2019 Jul; 98(30):e16575. PubMed ID: 31348290
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of dapagliflozin combined with hypoglycaemic drugs in treating type 2 diabetes mellitus: meta-analysis of randomised controlled trials.
Sun YN; Zhou Y; Chen X; Che WS; Leung SW
BMJ Open; 2014 Apr; 4(4):e004619. PubMed ID: 24710132
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of sodium-glucose co-transporter-2 inhibitors in type 2 diabetes mellitus: systematic review and network meta-analysis.
Zaccardi F; Webb DR; Htike ZZ; Youssef D; Khunti K; Davies MJ
Diabetes Obes Metab; 2016 Aug; 18(8):783-94. PubMed ID: 27059700
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to control hyperglycemia in type 2 diabetes: sodium glucose co-transport (SGLT) inhibitors: systematic review and meta-analysis of randomized trials.
Musso G; Gambino R; Cassader M; Pagano G
Ann Med; 2012 Jun; 44(4):375-93. PubMed ID: 21495788
[TBL] [Abstract][Full Text] [Related]
6. Dapagliflozin as monotherapy in drug-naive Asian patients with type 2 diabetes mellitus: a randomized, blinded, prospective phase III study.
Ji L; Ma J; Li H; Mansfield TA; T'joen CL; Iqbal N; Ptaszynska A; List JF
Clin Ther; 2014 Jan; 36(1):84-100.e9. PubMed ID: 24378206
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of dapagliflozin for type 1 diabetes: a meta-analysis of randomized controlled studies.
Ma J; Zhao Y; Fan H; Liu J
Afr Health Sci; 2021 Mar; 21(1):1-7. PubMed ID: 34394274
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of dapagliflozin combined with hypoglycemic drugs in treating type 2 diabetes: protocol for meta-analysis of randomized controlled trials.
Sun YN; Zhou Y; Chen X; Che WS; Leung SW
Syst Rev; 2013 Nov; 2():103. PubMed ID: 24225054
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of dapagliflozin plus saxagliptin vs monotherapy as added to metformin in patients with type 2 diabetes: A meta-analysis.
Zhuang Y; Song J; Ying M; Li M
Medicine (Baltimore); 2020 Jul; 99(30):e21409. PubMed ID: 32791755
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of dapagliflozin as a monotherapy for type 2 diabetes mellitus in Japanese patients with inadequate glycaemic control: a phase II multicentre, randomized, double-blind, placebo-controlled trial.
Kaku K; Inoue S; Matsuoka O; Kiyosue A; Azuma H; Hayashi N; Tokudome T; Langkilde AM; Parikh S
Diabetes Obes Metab; 2013 May; 15(5):432-40. PubMed ID: 23194084
[TBL] [Abstract][Full Text] [Related]
11. [Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride].
Strojek K; Yoon KH; Hruba V; Elze M; Langkilde AM; Parikh S
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S16-26. PubMed ID: 23529567
[TBL] [Abstract][Full Text] [Related]
12. A systematic review and dose-response meta-analysis on the efficacy of dapagliflozin in patients with type 1 diabetes mellitus.
Abu-Zaid A; Altowairqi AK; Dissanayaka T; Oganesyan A; Bhagavathul AS; Alhabeeb H; Baradhwan A; Alomar S; Tom S
Pharmacol Res; 2021 Mar; 165():105456. PubMed ID: 33515709
[TBL] [Abstract][Full Text] [Related]
13. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
Semlitsch T; Engler J; Siebenhofer A; Jeitler K; Berghold A; Horvath K
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD005613. PubMed ID: 33166419
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of empagliflozin for type 2 diabetes: a systematic review and meta-analysis.
Liakos A; Karagiannis T; Athanasiadou E; Sarigianni M; Mainou M; Papatheodorou K; Bekiari E; Tsapas A
Diabetes Obes Metab; 2014 Oct; 16(10):984-93. PubMed ID: 24766495
[TBL] [Abstract][Full Text] [Related]
15. Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years.
Wilding JP; Woo V; Rohwedder K; Sugg J; Parikh S;
Diabetes Obes Metab; 2014 Feb; 16(2):124-36. PubMed ID: 23911013
[TBL] [Abstract][Full Text] [Related]
16. [Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin].
Nauck M; del Prato S; Meier JJ; Durán-García S; Rohwedder K; Elze M; Parikh SJ
Dtsch Med Wochenschr; 2013 Apr; 138 Suppl 1():S6-15. PubMed ID: 23529570
[TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin compared with other oral anti-diabetes treatments when added to metformin monotherapy: a systematic review and network meta-analysis.
Goring S; Hawkins N; Wygant G; Roudaut M; Townsend R; Wood I; Barnett AH
Diabetes Obes Metab; 2014 May; 16(5):433-42. PubMed ID: 24237939
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of dapagliflozin monotherapy in people with Type 2 diabetes: a randomized double-blind placebo-controlled 102-week trial.
Bailey CJ; Morales Villegas EC; Woo V; Tang W; Ptaszynska A; List JF
Diabet Med; 2015 Apr; 32(4):531-41. PubMed ID: 25381876
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin, metformin XR, or both: initial pharmacotherapy for type 2 diabetes, a randomised controlled trial.
Henry RR; Murray AV; Marmolejo MH; Hennicken D; Ptaszynska A; List JF
Int J Clin Pract; 2012 May; 66(5):446-56. PubMed ID: 22413962
[TBL] [Abstract][Full Text] [Related]
20. Urinary tract and genital infections in patients with type 2 diabetes treated with sodium-glucose co-transporter 2 inhibitors: A meta-analysis of randomized controlled trials.
Li D; Wang T; Shen S; Fang Z; Dong Y; Tang H
Diabetes Obes Metab; 2017 Mar; 19(3):348-355. PubMed ID: 27862830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
